Provides that, upon request of the treating provider, the department must authorize coverage for a trial on an individual worker entitled to benefits under Title 51 RCW of an implantable medical device intended to treat chronic intractable pain otherwise approved by the United States food and drug administration and considered standard of care throughout the interventional pain medical community.

Declares that, if, after conducting the trial under this act, the treating provider finds individual success in curing or relieving the symptoms of the individual worker entitled to benefits under this title, the department shall determine that the implantable medical device intended to treat chronic intractable pain is proper and necessary treatment for the worker under RCW 51.36.010 and shall authorize coverage for full implantation and follow-up treatment.